The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Research Report 2024
Synopsis
Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.
The global ICAD (Intracranial Atherosclerotic Disease) Pathology market was valued at US$ 174 million in 2023 and is anticipated to reach US$ 316.2 million by 2030, witnessing a CAGR of 8.8% during the forecast period 2024-2030.
Global ICAD (Intracranial Atherosclerotic Disease) Pathology key players include Stryker, Balt, TERUMO, MicroPort, Acandis, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest market, with a share about 45%, followed by North America, with a share about 25 percent. In terms of product, Stent is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.
This report aims to provide a comprehensive presentation of the global market for ICAD (Intracranial Atherosclerotic Disease) Pathology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ICAD (Intracranial Atherosclerotic Disease) Pathology.
Report Scope
The ICAD (Intracranial Atherosclerotic Disease) Pathology market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global ICAD (Intracranial Atherosclerotic Disease) Pathology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ICAD (Intracranial Atherosclerotic Disease) Pathology manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Stryker
Balt
TERUMO
MicroPort
Acandis
Segment by Type
Stent
PTA Balloon
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of ICAD (Intracranial Atherosclerotic Disease) Pathology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.
The global ICAD (Intracranial Atherosclerotic Disease) Pathology market was valued at US$ 174 million in 2023 and is anticipated to reach US$ 316.2 million by 2030, witnessing a CAGR of 8.8% during the forecast period 2024-2030.
Global ICAD (Intracranial Atherosclerotic Disease) Pathology key players include Stryker, Balt, TERUMO, MicroPort, Acandis, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest market, with a share about 45%, followed by North America, with a share about 25 percent. In terms of product, Stent is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.
This report aims to provide a comprehensive presentation of the global market for ICAD (Intracranial Atherosclerotic Disease) Pathology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ICAD (Intracranial Atherosclerotic Disease) Pathology.
Report Scope
The ICAD (Intracranial Atherosclerotic Disease) Pathology market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global ICAD (Intracranial Atherosclerotic Disease) Pathology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ICAD (Intracranial Atherosclerotic Disease) Pathology manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Stryker
Balt
TERUMO
MicroPort
Acandis
Segment by Type
Stent
PTA Balloon
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of ICAD (Intracranial Atherosclerotic Disease) Pathology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Overview
1.1 Product Overview and Scope of ICAD (Intracranial Atherosclerotic Disease) Pathology
1.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Type
1.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Value Comparison by Type (2024-2030)
1.2.2 Stent
1.2.3 PTA Balloon
1.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Application
1.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Estimates and Forecasts
1.4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue 2019-2030
1.4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales 2019-2030
1.4.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Competition by Manufacturers
2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Manufacturers (2019-2024)
2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Manufacturers (2019-2024)
2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Average Price by Manufacturers (2019-2024)
2.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, Product Type & Application
2.7 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Competitive Situation and Trends
2.7.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest ICAD (Intracranial Atherosclerotic Disease) Pathology Players Market Share by Revenue
2.7.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 ICAD (Intracranial Atherosclerotic Disease) Pathology Retrospective Market Scenario by Region
3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region: 2019-2030
3.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region: 2019-2024
3.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region: 2025-2030
3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region: 2019-2030
3.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region: 2019-2024
3.3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region: 2025-2030
3.4 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Country
3.4.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2019-2030)
3.4.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Country
3.5.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2019-2030)
3.5.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Country
3.6.1 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2019-2030)
3.6.3 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Country
3.7.1 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2019-2030)
3.7.3 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Country
3.8.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2019-2030)
3.8.3 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019-2030)
4.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2019-2024)
4.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2025-2030)
4.1.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2019-2030)
4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2019-2030)
4.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2019-2024)
4.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2025-2030)
4.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2019-2030)
4.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (2019-2030)
5 Segment by Application
5.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019-2030)
5.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2019-2024)
5.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2025-2030)
5.1.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2019-2030)
5.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2019-2030)
5.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2019-2024)
5.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2025-2030)
5.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application (2019-2030)
5.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Stryker
6.1.1 Stryker Corporation Information
6.1.2 Stryker Description and Business Overview
6.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
6.1.5 Stryker Recent Developments/Updates
6.2 Balt
6.2.1 Balt Corporation Information
6.2.2 Balt Description and Business Overview
6.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
6.2.5 Balt Recent Developments/Updates
6.3 TERUMO
6.3.1 TERUMO Corporation Information
6.3.2 TERUMO Description and Business Overview
6.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2019-2024)
6.3.4 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
6.3.5 TERUMO Recent Developments/Updates
6.4 MicroPort
6.4.1 MicroPort Corporation Information
6.4.2 MicroPort Description and Business Overview
6.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
6.4.5 MicroPort Recent Developments/Updates
6.5 Acandis
6.5.1 Acandis Corporation Information
6.5.2 Acandis Description and Business Overview
6.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
6.5.5 Acandis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Chain Analysis
7.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Production Mode & Process
7.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Marketing
7.4.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Channels
7.4.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors
7.5 ICAD (Intracranial Atherosclerotic Disease) Pathology Customers
8 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Dynamics
8.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Trends
8.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Drivers
8.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Challenges
8.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
